Interview with Colette Côté, Ph.D. : Chief Portfolio Officer and General Manager of PathoQuest’s U.S. subsidiary located in Wayne, PA.
A funny way to meet withMeet Colette Côté the Chief Portfolio Officer and General Manager of PathoQuest US subsidiary and, to understand how NGS solutions that identify adventitious agents using a rapid, animal-free, comprehensive testing approach can accelerate the development timelines of biologics.
This digital event will allow you to exchange with NGS experts around NGS for QC testing of biologics hot topics like the latest result of the exclusive study comparing NGS to animal testing.
Olivier Matteudi, has over 30 years of experience as a genomic sales engineer and key account manager. Join us to welcome him as he is joining PathoQuest as a Sales Manager and bringing his NGS expertise to the biologics services customers in Europe.
PathoQuest fully supports the #worldhealthday and works every day to improve the care of patients by accelerating access to innovative medicines
Annoucement of the appointment of Eric Cazergue as Chief Financial Officer. Mr. Cazergue’s international career in finance roles within the healthcare industry will be a key asset supporting PathoQuest’s scale-up and global expansion efforts.
PathoQuest Appoints Colette Côté as Chief Portfolio Officer and General Manager of the Company’s U.S. Subsidiary
Annoucement of the appointment of Colette Côté, Ph.D. as Chief Portfolio Officer and General Manager of PathoQuest’s U.S. subsidiary located in Wayne, PA. Ms. Côté’s expertise and long history of innovating, developing, and applying tailored NGS-based assays to the biopharma biosafety testing space will further drive the expansion and growth of PathoQuest’s NGS-based services portfolio within the North American market.